CRISPR Therapeutics AGCRSPNASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, above historical average, structural decline.
Left:
||||
Year-over-year operating income growth rate
Latest
-109.66%
↑ 24% above average
Average (9y)
-144.02%
Historical baseline
Range
High:205.39%
Low:-858.31%
CAGR
-10.2%
Structural decline
| Period | Value |
|---|---|
| 2024 | -109.66% |
| 2023 | 66.94% |
| 2022 | -280.22% |
| 2021 | 205.39% |
| 2020 | -858.31% |
| 2019 | 129.41% |
| 2018 | -145.86% |
| 2017 | 5.11% |
| 2016 | -164.80% |
| 2015 | -288.25% |